Form 4: Elevance Health Director Bahija Jallal Reports Acquisition of Deferred Stock Units

Director Bahija Jallal reported the acquisition of 388 deferred stock units of Elevance Health, Inc.

Summary

• On May 15, 2024, Bahija Jallal, a director of Elevance Health, Inc., acquired 388 deferred stock units under the company's Board of Directors Compensation Program.
• These deferred stock units will be payable in Elevance Health common stock either five years from the grant date or upon cessation of board membership, unless a later date is designated.
• Following the transaction, Jallal directly owns 4,187 shares of Elevance Health common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing regarding stock ownership, indicating a neutral sentiment.

Future Outlook

The deferred stock units will be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Industry Context

This filing is a routine disclosure of a director's acquisition of deferred stock units, which is a common form of compensation for board members in publicly traded companies.

Stakeholder Impact

• The acquisition of deferred stock units by a director could be viewed positively by shareholders as it aligns the director's interests with the long-term performance of the company.

Key Dates